EcoDrugPlus

Ribosomal Protein L39

Ensembl ID : ENSPFOG00000017441
Gene Symbol: RPL39
1 Cross references
146 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSPFOG00000008365
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSPFOG00000017339
Gene Symbol: RPL5
4 Cross references
469 Possible Orthologues:

Ribosomal Protein L5b

Ensembl ID : ENSPFOG00000016503
Gene Symbol: RPL5B
2 Cross references
455 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSPFOG00000012600
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSPFOG00000013065
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSPFOG00000015861
Gene Symbol: RPL7A
4 Cross references
369 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSPFOG00000007707
Gene Symbol: RPL7A
4 Cross references
369 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSPFOG00000014562
Gene Symbol: RPL8
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSPFOG00000010408
Gene Symbol: RPL9
3 Cross references
509 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSPFOG00000015072
Gene Symbol: RPS10
3 Cross references
379 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSPFOG00000014915
Gene Symbol: RPS11
1 Cross references
286 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).